Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.
The role of fractalkine (CX3CL1) in regulation of CD4(+) cell migration to the central nervous system in patients with relapsing-remitting multiple sclerosis.
Development and validation of the multiple sclerosis questionnaire for the evaluation of job difficulties (MSQ-Job).
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review.
Mitochondrial DNA sequence variation in multiple sclerosis.
Glioblastoma following treatment with fingolimod for relapsing-remitting multiple sclerosis.
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis.
Ocular motor signatures of cognitive dysfunction in multiple sclerosis.
Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
Immunophenotype of mouse cerebral hemispheres-derived neural precursor cells.
Fatigue, Sleep Quality, and Disability in Relation to Quality of Life in Multiple Sclerosis.
Intracerebroventricular administration of TNF-like weak inducer of apoptosis induces depression-like behavior and cognitive dysfunction in non-autoimmune mice.
Valuing the Endangered Species Antirrhinum lopesianum: Neuroprotective Activities and Strategies for in vitro Plant Propagation.
A Fresh Look at the Potential Mechanisms of Progressive Muscle Relaxation Therapy on Depression in Female Patients With Multiple Sclerosis.
Progranulin genetic polymorphisms influence progression of disability and relapse recovery in multiple sclerosis.
Oligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update.
Diagnostic tools for assessment of urinary dysfunction in MS patients without urinary disturbances.
Opportunistic DNA Recombination with Epstein-Barr Virus at Sites of Control Region Rearrangements Mediating JC Virus Neurovirulence.
Therapeutic efficacy of erythropoietin in experimental autoimmune encephalomyelitis in mice, a model of multiple sclerosis.
Vitamin D3 Induces IDO(+) Tolerogenic DCs and Enhances Treg, Reducing the Severity of EAE.
Rationale and design of a randomized controlled, clinical trial investigating a comprehensive exercise stimulus for improving mobility disability outcomes in persons with multiple sclerosis.
Evidence for efficacy of a drug widely used without authorisation in multiple sclerosis: mycophenolate mofetil.
Studies in Experimental Autoimmune Encephalomyelitis Do Not Support Developmental Bisphenol A Exposure as an Environmental Factor in Increasing Multiple Sclerosis Risk.
Is the 'liberation procedure' for multiple sclerosis really liberating?
The usefulness of brain MRI at onset in the differentiation of multiple sclerosis and seropositive neuromyelitis optica spectrum disorders.

Pages